Giarc,
I'm reading that ROW rights come after the PWS P2 trials and before NDA approval of Trofinetide. This table hasn't changed in the multiple presentations over the last several months? Irrespective I think we'll here something soon re: ROW rights maybe with a big pharma.
For me the below snippet is the really exciting thing that I'm eagerly looking forward to in the future
- Forums
- ASX - By Stock
- NEU
- Ann: Jefferies London Healthcare Conference 2022 presentation
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$12.85

Ann: Jefferies London Healthcare Conference 2022 presentation, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.85 |
Change
0.000(0.00%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16 | $14.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.07 | 592 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16 | 14.070 |
6 | 859 | 13.770 |
1 | 270 | 13.690 |
1 | 11 | 13.560 |
1 | 1 | 13.540 |
Price($) | Vol. | No. |
---|---|---|
12.070 | 592 | 6 |
12.210 | 2792 | 10 |
12.650 | 348 | 4 |
12.680 | 46 | 2 |
12.710 | 1018 | 2 |
Last trade - 10.05am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online